• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真实人体上呼吸道模型中药物吸入的数值与实验分析。

Numerical and Experimental Analysis of Drug Inhalation in Realistic Human Upper Airway Model.

作者信息

Momeni Larimi Morsal, Babamiri Arash, Biglarian Mohit, Ramiar Abas, Tabe Reza, Inthavong Kiao, Farnoud Ali

机构信息

Faculty of Mechanical Engineering, Babol Noshirvani University of Technology, Babol P.O. Box 484, Iran.

Department of Engineering, University of Kurdistan, Kurdistan 66177-15175, Iran.

出版信息

Pharmaceuticals (Basel). 2023 Mar 7;16(3):406. doi: 10.3390/ph16030406.

DOI:10.3390/ph16030406
PMID:36986505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10054804/
Abstract

The demand for a more efficient and targeted method for intranasal drug delivery has led to sophisticated device design, delivery methods, and aerosol properties. Due to the complex nasal geometry and measurement limitations, numerical modeling is an appropriate approach to simulate the airflow, aerosol dispersion, and deposition for the initial assessment of novel methodologies for better drug delivery. In this study, a CT-based, 3D-printed model of a realistic nasal airway was reconstructed, and airflow pressure, velocity, turbulent kinetic energy (TKE), and aerosol deposition patterns were simultaneously investigated. Different inhalation flowrates (5, 10, 15, 30, and 45 L/min) and aerosol sizes (1, 1.5, 2.5, 3, 6, 15, and 30 µm) were simulated using laminar and SST viscous models, with the results compared and verified by experimental data. The results revealed that from the vestibule to the nasopharynx, the pressure drop was negligible for flow rates of 5, 10, and 15 L/min, while for flow rates of 30 and 40 L/min, a considerable pressure drop was observed by approximately 14 and 10%, respectively. However, from the nasopharynx and trachea, this reduction was approximately 70%. The aerosol deposition fraction alongside the nasal cavities and upper airway showed a significant difference in pattern, dependent on particle size. More than 90% of the initiated particles were deposited in the anterior region, while just under 20% of the injected ultrafine particles were deposited in this area. The turbulent and laminar models showed slightly different values for the deposition fraction and efficiency of drug delivery for ultrafine particles (about 5%); however, the deposition pattern for ultrafine particles was very different.

摘要

对更高效、更具针对性的鼻内给药方法的需求推动了精密的装置设计、给药方式和气溶胶特性的发展。由于鼻腔几何结构复杂且测量存在局限性,数值模拟是一种合适的方法,可用于模拟气流、气溶胶扩散和沉积,以便对改善药物递送的新方法进行初步评估。在本研究中,重建了基于CT的逼真鼻气道3D打印模型,并同时研究了气流压力、速度、湍流动能(TKE)和气溶胶沉积模式。使用层流和SST粘性模型模拟了不同的吸入流速(5、10、15、30和45 L/min)和气溶胶粒径(1、1.5、2.5、3、6、15和30 µm),并将结果与实验数据进行了比较和验证。结果显示,从前庭到鼻咽,对于5、10和15 L/min的流速,压降可忽略不计,而对于30和40 L/min的流速,分别观察到约14%和10%的显著压降。然而,从鼻咽到气管,这种压降减少了约70%。鼻腔和上呼吸道沿线的气溶胶沉积分数在模式上显示出显著差异,这取决于颗粒大小。超过90%的起始颗粒沉积在前部区域,而注入的超细颗粒中只有不到20%沉积在该区域。湍流模型和层流模型显示,超细颗粒的沉积分数和药物递送效率的值略有不同(约5%);然而,超细颗粒的沉积模式非常不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/07b988c37b15/pharmaceuticals-16-00406-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/67a591e9d28f/pharmaceuticals-16-00406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/ca7a35907429/pharmaceuticals-16-00406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/cc21865b524c/pharmaceuticals-16-00406-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/07b26334bcbb/pharmaceuticals-16-00406-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/17055f06ff6b/pharmaceuticals-16-00406-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/4237a1a0a600/pharmaceuticals-16-00406-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/7b21f618d156/pharmaceuticals-16-00406-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/e3aed510709a/pharmaceuticals-16-00406-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/a5b00422c0f5/pharmaceuticals-16-00406-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/4c46d8c11167/pharmaceuticals-16-00406-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/4003f2eab419/pharmaceuticals-16-00406-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/ad10b1d05ffb/pharmaceuticals-16-00406-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/66f891d52212/pharmaceuticals-16-00406-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/07b988c37b15/pharmaceuticals-16-00406-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/67a591e9d28f/pharmaceuticals-16-00406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/ca7a35907429/pharmaceuticals-16-00406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/cc21865b524c/pharmaceuticals-16-00406-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/07b26334bcbb/pharmaceuticals-16-00406-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/17055f06ff6b/pharmaceuticals-16-00406-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/4237a1a0a600/pharmaceuticals-16-00406-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/7b21f618d156/pharmaceuticals-16-00406-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/e3aed510709a/pharmaceuticals-16-00406-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/a5b00422c0f5/pharmaceuticals-16-00406-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/4c46d8c11167/pharmaceuticals-16-00406-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/4003f2eab419/pharmaceuticals-16-00406-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/ad10b1d05ffb/pharmaceuticals-16-00406-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/66f891d52212/pharmaceuticals-16-00406-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/10054804/07b988c37b15/pharmaceuticals-16-00406-g014.jpg

相似文献

1
Numerical and Experimental Analysis of Drug Inhalation in Realistic Human Upper Airway Model.真实人体上呼吸道模型中药物吸入的数值与实验分析。
Pharmaceuticals (Basel). 2023 Mar 7;16(3):406. doi: 10.3390/ph16030406.
2
Targeted drug delivery with polydisperse particle transport and deposition in patient-specific upper airway during inhalation and exhalation.靶向药物输送与多分散颗粒在吸入和呼出过程中的患者特定上呼吸道中的传输和沉积。
Respir Physiol Neurobiol. 2023 Feb;308:103986. doi: 10.1016/j.resp.2022.103986. Epub 2022 Nov 14.
3
Dry powder inhaler aerosol deposition in a model of tracheobronchial airways: Validating CFD predictions with in vitro data.干粉吸入器气溶胶在气管支气管气道模型中的沉积:用体外数据验证 CFD 预测。
Int J Pharm. 2020 Sep 25;587:119599. doi: 10.1016/j.ijpharm.2020.119599. Epub 2020 Jul 11.
4
Computational fluid-particle dynamics modeling of ultrafine to coarse particles deposition in the human respiratory system, down to the terminal bronchiole.在人体呼吸系统中,对超细至粗颗粒的沉积进行计算流-粒子动力学建模,直至终末细支气管。
Comput Methods Programs Biomed. 2023 Jul;237:107589. doi: 10.1016/j.cmpb.2023.107589. Epub 2023 May 6.
5
Numerical analysis of airflow and particle deposition in multi-fidelity designs of nasal replicas following nasal administration.鼻腔给药后鼻腔复制品多保真度设计中气流和颗粒沉积的数值分析。
Comput Methods Programs Biomed. 2023 Nov;241:107778. doi: 10.1016/j.cmpb.2023.107778. Epub 2023 Aug 25.
6
Investigation of airflow at different activity conditions in a realistic model of human upper respiratory tract.在真实的人类上呼吸道模型中对不同活动条件下的气流进行研究。
Comput Methods Biomech Biomed Engin. 2021 Feb;24(2):173-187. doi: 10.1080/10255842.2020.1819256. Epub 2020 Sep 17.
7
Comparison of micron- and nano-particle transport in the human nasal cavity with a focus on the olfactory region.人体鼻腔内微米级和纳米级颗粒传输的比较,重点关注嗅觉区域。
Comput Biol Med. 2021 Jan;128:104103. doi: 10.1016/j.compbiomed.2020.104103. Epub 2020 Nov 5.
8
Numerical investigation of transient transport and deposition of microparticles under unsteady inspiratory flow in human upper airways.人体上呼吸道非定常吸气流动下微粒瞬态输运与沉积的数值研究。
Respir Physiol Neurobiol. 2017 Oct;244:56-72. doi: 10.1016/j.resp.2017.06.005. Epub 2017 Jul 1.
9
Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway.气管支气管气道模型中优化加压计量吸入器(pMDI)的流场结构和颗粒沉积分析。
Eur J Pharm Sci. 2021 Sep 1;164:105911. doi: 10.1016/j.ejps.2021.105911. Epub 2021 Jun 12.
10
Transport and deposition of ultrafine particles in the upper tracheobronchial tree: a comparative study between approximate and realistic respiratory tract models.超细颗粒在上呼吸道的输送和沉积:近似和真实呼吸道模型的比较研究。
Comput Methods Biomech Biomed Engin. 2021 Aug;24(10):1125-1135. doi: 10.1080/10255842.2020.1869220. Epub 2021 Jan 7.

引用本文的文献

1
Computational Rhinology: Unraveling Discrepancies between In Silico and In Vivo Nasal Airflow Assessments for Enhanced Clinical Decision Support.计算鼻科学:揭示计算机模拟与体内鼻气流评估之间的差异以增强临床决策支持
Bioengineering (Basel). 2024 Feb 28;11(3):239. doi: 10.3390/bioengineering11030239.
2
Physical Conditions Prevailing in the Nasal and Maxillary Sinus Cavities Based on Numerical Simulation.基于数值模拟的鼻腔及上颌窦腔内的物理条件。
Medicina (Kaunas). 2023 Jun 5;59(6):1094. doi: 10.3390/medicina59061094.

本文引用的文献

1
Effect of laryngeal jet on dry powder inhaler aerosol deposition: a numerical simulation.喉喷对干粉吸入器气溶胶沉积的影响:数值模拟。
Comput Methods Biomech Biomed Engin. 2023 Oct-Dec;26(15):1859-1874. doi: 10.1080/10255842.2022.2152280. Epub 2022 Dec 13.
2
Targeted drug delivery with polydisperse particle transport and deposition in patient-specific upper airway during inhalation and exhalation.靶向药物输送与多分散颗粒在吸入和呼出过程中的患者特定上呼吸道中的传输和沉积。
Respir Physiol Neurobiol. 2023 Feb;308:103986. doi: 10.1016/j.resp.2022.103986. Epub 2022 Nov 14.
3
Pulsatile Bi-Directional Aerosol Flow Affects Aerosol Delivery to the Intranasal Olfactory Region: A Patient-Specific Computational Study.
脉动双向气溶胶流对鼻内嗅觉区域气溶胶输送的影响:一项针对个体患者的计算研究。
Front Pharmacol. 2021 Nov 23;12:746420. doi: 10.3389/fphar.2021.746420. eCollection 2021.
4
Effect of swirling flow and particle-release pattern on drug delivery to human tracheobronchial airways.旋流和颗粒释放模式对药物输送到人体气管支气管气道的影响。
Biomech Model Mechanobiol. 2021 Dec;20(6):2451-2469. doi: 10.1007/s10237-021-01518-5. Epub 2021 Sep 13.
5
Acoustic drug delivery to the maxillary sinus.上颌窦的声药物传递。
Int J Pharm. 2021 Sep 5;606:120927. doi: 10.1016/j.ijpharm.2021.120927. Epub 2021 Jul 23.
6
The effect of decongestion on nasal airway patency and airflow.充血消退对鼻腔气道通畅性和气流的影响。
Sci Rep. 2021 Jul 13;11(1):14410. doi: 10.1038/s41598-021-93769-6.
7
Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway.气管支气管气道模型中优化加压计量吸入器(pMDI)的流场结构和颗粒沉积分析。
Eur J Pharm Sci. 2021 Sep 1;164:105911. doi: 10.1016/j.ejps.2021.105911. Epub 2021 Jun 12.
8
Simulation of patient-specific bi-directional pulsating nasal aerosol dispersion and deposition with clockwise 45° and 90° nosepieces.使用顺时针45°和90°鼻罩对患者特定的双向脉动鼻腔气溶胶扩散和沉积进行模拟。
Comput Biol Med. 2020 Aug;123:103816. doi: 10.1016/j.compbiomed.2020.103816. Epub 2020 May 18.
9
Acoustically-driven drug delivery to maxillary sinuses: Aero-acoustic analysis.声驱动药物输送至上颌窦:气动声学分析。
Eur J Pharm Sci. 2020 Aug 1;151:105398. doi: 10.1016/j.ejps.2020.105398. Epub 2020 May 30.
10
Characterization of the Airflow within an Average Geometry of the Healthy Human Nasal Cavity.健康人体鼻腔平均几何结构内气流特征。
Sci Rep. 2020 Feb 28;10(1):3755. doi: 10.1038/s41598-020-60755-3.